Poseida Therapeutics Stock Profit Margin
| PSTX Stock | USD 9.31 0.02 0.21% |
Poseida Therapeutics fundamentals help investors to digest information that contributes to Poseida Therapeutics' financial success or failures. It also enables traders to predict the movement of Poseida Stock. The fundamental analysis module provides a way to measure Poseida Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Poseida Therapeutics stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (1.91) | (1.81) |
Poseida | Profit Margin |
Poseida Therapeutics Company Profit Margin Analysis
Poseida Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Poseida Therapeutics Profit Margin | (0.40) % |
Most of Poseida Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Poseida Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Poseida Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Poseida Therapeutics is extremely important. It helps to project a fair market value of Poseida Stock properly, considering its historical fundamentals such as Profit Margin. Since Poseida Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Poseida Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Poseida Therapeutics' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Poseida Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Poseida Therapeutics has a Profit Margin of -0.4028%. This is 96.41% lower than that of the Biotechnology sector and 98.25% lower than that of the Health Care industry. The profit margin for all United States stocks is 68.28% lower than that of the firm.
Poseida Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Poseida Therapeutics from analyzing Poseida Therapeutics' financial statements. These drivers represent accounts that assess Poseida Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Poseida Therapeutics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 551.3M | 370.2M | 278.3M | 388.5M | 344.0M | 545.8M |
Poseida Therapeutics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Poseida Therapeutics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Poseida Therapeutics' managers, analysts, and investors.Environmental | Governance | Social |
Poseida Fundamentals
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | (0.40) % | ||||
| Operating Margin | 0.28 % | ||||
| Current Valuation | 759.29 M | ||||
| Shares Outstanding | 97.47 M | ||||
| Shares Owned By Insiders | 27.64 % | ||||
| Shares Owned By Institutions | 58.48 % | ||||
| Number Of Shares Shorted | 4.61 M | ||||
| Price To Earning | 214.00 X | ||||
| Price To Book | 10.40 X | ||||
| Price To Sales | 6.03 X | ||||
| Revenue | 64.7 M | ||||
| Gross Profit | (22.41 M) | ||||
| EBITDA | (109.04 M) | ||||
| Net Income | (123.43 M) | ||||
| Cash And Equivalents | 142.56 M | ||||
| Cash Per Share | 1.66 X | ||||
| Total Debt | 85.42 M | ||||
| Debt To Equity | 1.39 % | ||||
| Current Ratio | 3.69 X | ||||
| Book Value Per Share | 0.90 X | ||||
| Cash Flow From Operations | (92.17 M) | ||||
| Short Ratio | 8.30 X | ||||
| Earnings Per Share | (0.63) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 9.5 | ||||
| Number Of Employees | 350 | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 909.36 M | ||||
| Total Asset | 273.88 M | ||||
| Retained Earnings | (594.29 M) | ||||
| Working Capital | 155.16 M | ||||
| Current Asset | 10.59 M | ||||
| Current Liabilities | 5.1 M | ||||
| Net Asset | 273.88 M |
About Poseida Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Poseida Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poseida Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poseida Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Poseida Stock Analysis
When running Poseida Therapeutics' price analysis, check to measure Poseida Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poseida Therapeutics is operating at the current time. Most of Poseida Therapeutics' value examination focuses on studying past and present price action to predict the probability of Poseida Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poseida Therapeutics' price. Additionally, you may evaluate how the addition of Poseida Therapeutics to your portfolios can decrease your overall portfolio volatility.